Oral Delivery of Glucagon-like Peptide-1 and Analogs: Alternatives for Diabetes Control?-Reference-Cited by-同舟云学术

Oral Delivery of Glucagon-like Peptide-1 and Analogs: Alternatives for Diabetes Control?

Published:2012-11 Issue:6 Volume:6 Page:1486-1497
ISSN:1932-2968
Container-title:Journal of Diabetes Science and Technology
language:en
Short-container-title:J Diabetes Sci Technol

Author:

Araújo Francisca¹²,Fonte Pedro¹³,Santos Hélder A.⁴,Sarmento Bruno¹²⁵

Affiliation:

1. Department of Pharmaceutical Sciences, Centro de Investigação em Ciências da Saúde, Health Sciences Research Center, Instituto Superior de Ciências da Saúde, CESPU, Gandra, Portugal

2. Instituto de Engenharia Biomédica, University of Porto, Porto, Portugal

3. Department of Chemistry, Faculty of Pharmacy, REQUIMTE, University of Porto, Porto, Portugal

4. Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland

5. Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Porto, Portugal

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/193229681200600630

Reference96 articles.

1. Global estimates of the prevalence of diabetes for 2010 and 2030

2. Glycaemic control in type 2 diabetes: Targets and new therapies

3. Diabetes mellitus: new drugs for a new epidemic

4. GLP-1 based therapy for type 2 diabetes

5. Peptide Drug Delivery Strategies for the Treatment of Diabetes

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges;Expert Opinion on Drug Delivery;2024-07-02

2. Enhancing the Therapeutic Efficacy of GLP-1 for Hyperglycemia Treatment: Overcoming Barriers of Oral Gene Therapy with Taurocholic Acid-Conjugated Protamine Sulfate and Calcium Phosphate;ACS Nanoscience Au;2024-04-05

3. New insights into nanomedicines for oral delivery of glucagon‐like peptide‐1 analogs;WIREs Nanomedicine and Nanobiotechnology;2024-03

4. Self-assembled nanomicelles for oral delivery of luteolin utilizing the intestinal lymphatic pathway to target pancreatic cancer;Nanoscale;2024

5. Nanoparticle-Based Delivery Platforms for the Enhanced Oral Delivery of Peptides/Proteins;Therapeutic Delivery;2023-12